Intracranial Pressure Monitoring Devices Market Size & Share, by Product (Invasive, Non-Invasive); Application; End User - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Intracranial Pressure Monitoring Devices Industry - Regional Synopsis

North America Market Analysis

North America intracranial pressure monitoring devices market is poised to dominate over 53.8% revenue share by 2037. The region’s supremacy is accredited to factors including a high prevalence of distressing brain damage, the existence of foremost market players, and satisfactory reimbursement policies. Besides, the rising prevalence of migraine in the region is also enhancing the demand of the market. As per the May 2024 NLM article, migraine has severely affected the population with an incidence rate ranging from 11.7% to 14.7%, thereby a positive outlook for market upliftment.

The intracranial pressure (ICP) monitoring devices market in the U.S. is rising exponentially owing to the presence of robust medical infrastructure, rising healthcare spending, government initiatives, and the adoption of neurostimulation devices. According to the December 2024 CMS report, the regional health spending was USD 4.9 trillion, denoting an increase of 7.5% as of 2023. Therefore, this allows investment strategies by the government to provide increasing funds for the development of technology and facilities in the country. Additionally, the establishment of the America Society of Craniofacial Surgery (ASCFS), crucial for creating awareness, is also a driving factor for the market in the country.

The intracranial pressure monitoring devices market in Canada is likely to witness substantial growth during the forecast period driven by the introduction of the latest innovative monitoring devices. For instance, in November 2024, Medical Device Network unveiled Aktiia’s introduction of its groundbreaking blood pressure monitoring wearables in the country. This includes the launch of a continuous blood pressure monitoring (CBPM) bracelet after securing Health Canada approval. This is an effective contribution to the market as well as catering to the health of the population through standard monitoring capabilities.

APAC Market Statistics

The intracranial pressure monitoring devices market in Asia Pacific is gaining a positive influence and is projected to witness lucrative growth during the forecast timeline. Factors such as increasing incidences of trauma and sports injury are highly responsible for the expansion of the market within the region. For instance, as per the February 2021 NLM article, a clinical study was conducted on 782 athletes in Korea, wherein 141 injuries were recorded and 15.4% of athletes were severely suffering from injuries. Besides, 71.4% of injuries occurred among sport-climbing athletes, thereby increasing the exposure of the market in the region.

The market in India is highly driven by the availability of both invasive and non-invasive device technologies. According to a clinical study published by NLM in April 2022, 122 patients in the country suffering from idiopathic intracranial hypertension (IIH) were evaluated, out of which headache was the most common symptom among 114 that is 93.4% of the patient pool. Therefore, with such disorders, the country is in huge need of intracranial pressure monitoring devices to minutely identify symptoms and provide treatment solutions.

The market in China is witnessing significant growth opportunities owing to the occurrence of neurological disorders and innovation in technology advancements. According to the February 2023 Frontiers Organization report, a clinical study was conducted on the provision of neuro care in the country. It was found that approximately 96,201 patients suffered from neurological illnesses with an average fatality rate of 4.1%. In addition, the study reported that cerebrovascular disease was the most common form of severe neurological disease with a prevalence rate of 55.2%, thus driving the market demand.